CloudMD Software & Services Stock Forecast, Price & News

+0.01 (+0.54 %)
(As of 07/29/2021 03:59 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume337,100 shs
Average Volume1.26 million shs
Market CapitalizationC$431.44 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive DOC News and Ratings via Email

Sign-up to receive the latest news and ratings for CloudMD Software & Services and its competitors with MarketBeat's FREE daily newsletter.

CloudMD Software & Services logo

About CloudMD Software & Services

CloudMD Software & Services Inc., a healthcare technology company, provides SaaS based health technology solutions to medical clinics in North America. It offers CloudMD telemedicine application, a telemedicine platform that connects patients to licensed physician through videoconferencing technology; operates a network of inter-connected medical clinics; and Re:Function, an integrated network of 8 rehabilitation clinics that offers various rehabilitation services. The company also retails prescription drugs, over-the-counter drugs, and other front store items through two pharmacies, as well as provides clinical services, such as medical reviews and compounding; and provides cloud-based electronic medical records (EMR) software, medical billing and practice management software, and various telemedicine platforms to medical professionals, as well as digital platforms to serve individuals for their eyecare and specialty drug needs. In addition, it offers JunoEMR, a cloud-based EMR solution; MyHealthAccess, an online patient portal for online appointment booking and telemedicine visits; Benchmark, a suite of cloud-based medical practice solutions; and ClinicAid, a medical billing software. Further, the company provides Livecare Connect, a telemedicine platform; IDYA4, a health data integration and security technology platform; VisionPros, an online eyecare platform that offers contact lenses and eyeglasses under the KIND brand; Rxi, a specialty drug wholesaler, pharmacy, and technology/patient support program administrator. Additionally, it provides enterprise health solutions, including mental health support; employee and student assistance programs; healthcare navigation and specialist; rehabilitation and assessments; education; and absence management. The company was formerly known as Premier Health Group Inc. and changed its name to CloudMD Software & Services Inc. in February 2020. The company was incorporated in 2013 and is headquartered in Victoria, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.79 out of 5 stars

Analyst Opinion: 3.5Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

CloudMD Software & Services (CVE:DOC) Frequently Asked Questions

Is CloudMD Software & Services a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CloudMD Software & Services in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CloudMD Software & Services stock.
View analyst ratings for CloudMD Software & Services
or view top-rated stocks.

What stocks does MarketBeat like better than CloudMD Software & Services?

Wall Street analysts have given CloudMD Software & Services a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CloudMD Software & Services wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is CloudMD Software & Services' next earnings date?

CloudMD Software & Services is scheduled to release its next quarterly earnings announcement on Monday, August 30th 2021.
View our earnings forecast for CloudMD Software & Services

How were CloudMD Software & Services' earnings last quarter?

CloudMD Software & Services Inc. (CVE:DOC) released its earnings results on Thursday, May, 27th. The company reported ($0.03) earnings per share (EPS) for the quarter. The business had revenue of $8.78 million for the quarter.
View CloudMD Software & Services' earnings history

What price target have analysts set for DOC?

1 Wall Street analysts have issued 1-year target prices for CloudMD Software & Services' stock. Their forecasts range from C$3.50 to C$4.25. On average, they expect CloudMD Software & Services' stock price to reach C$3.88 in the next year. This suggests a possible upside of 107.2% from the stock's current price.
View analysts' price targets for CloudMD Software & Services
or view top-rated stocks among Wall Street analysts.

Who are CloudMD Software & Services' key executives?

CloudMD Software & Services' management team includes the following people:
  • Dr. Essam Hamza M.D., CEO & Director (Age 50, Pay $240k)
  • Mr. Mena Beshay C.M.A., CPA, Global Head of Corp. Devel.
  • Dr. Amit Mathur, Pres & Director
  • Mr. Daniel Lee C.A., CPA, CPA, CA, Chief Financial Officer
  • Ms. Kanchan Thindal M.B.A., COO & Corp. Sec.
  • Ms. Julia Becker, VP of Investor Relations
  • Mr. Richard Atkins, Sr. VP of Sales
  • Dr. David Ostrow M.D., Chief Medical Officer
  • Ms. Karen Adams, Chief Health Innovation Officer

Who are some of CloudMD Software & Services' key competitors?

What other stocks do shareholders of CloudMD Software & Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CloudMD Software & Services investors own include Alpha Lithium (ALLIF), WELL Health Technologies (WEL), Absolute Software Co. (ABT.TO) (ABT), Air Canada (AC), Aphria (APHA), (AZN), BlackBerry (BB), Brookfield Property Partners (BPY.UN), Chemesis International (CADMF) and Cerus (CERS).

What is CloudMD Software & Services' stock symbol?

CloudMD Software & Services trades on the Canadian Venture Exchange (CVE) under the ticker symbol "DOC."

How do I buy shares of CloudMD Software & Services?

Shares of DOC and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is CloudMD Software & Services' stock price today?

One share of DOC stock can currently be purchased for approximately C$1.87.

How much money does CloudMD Software & Services make?

CloudMD Software & Services has a market capitalization of C$431.44 million and generates C$20.73 million in revenue each year.

What is CloudMD Software & Services' official website?

The official website for CloudMD Software & Services is

This page was last updated on 7/30/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.